# EXKIVITY
> **NDA215310** · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2021-09-15
## Drug
- **FDA Application Number:** NDA215310
- **Application type:** New Drug Application
- **Brand name:** EXKIVITY
- **Generic name:** Mobocertinib Succinate
- **Active ingredients:** MOBOCERTINIB SUCCINATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** TAKEDA PHARMS USA
- **First approval:** 2021-09-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215310)
---
*MORVS · CC0 1.0*